The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 24, 2015

Filed:

Aug. 20, 2007
Applicants:

Ping Lin, San Diego, CA (US);

Andrea Ghetti, San Diego, CA (US);

Wenge Shi, San Marcos, CA (US);

Mengjia Tang, San Diego, CA (US);

Gioulnar I. Harvie, San Diego, CA (US);

Huimin Tao, San Diego, CA (US);

Guoliang Tao, San Diego, CA (US);

Lei Wu, San Diego, CA (US);

David Cerny, San Diego, CA (US);

Jia Xu, San Diego, CA (US);

Douglas T. Yamanishi, Redondo Beach, CA (US);

Inventors:

Ping Lin, San Diego, CA (US);

Andrea Ghetti, San Diego, CA (US);

Wenge Shi, San Marcos, CA (US);

Mengjia Tang, San Diego, CA (US);

Gioulnar I. Harvie, San Diego, CA (US);

Huimin Tao, San Diego, CA (US);

Guoliang Tao, San Diego, CA (US);

Lei Wu, San Diego, CA (US);

David Cerny, San Diego, CA (US);

Jia Xu, San Diego, CA (US);

Douglas T. Yamanishi, Redondo Beach, CA (US);

Assignee:

Aviva Biosciences Corporation, San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/24 (2006.01); C12N 5/09 (2010.01); G01N 33/50 (2006.01); G01N 33/543 (2006.01); G01N 33/569 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0693 (2013.01); G01N 33/5094 (2013.01); G01N 33/54346 (2013.01); G01N 33/56972 (2013.01); G01N 33/574 (2013.01); G01N 2333/70525 (2013.01); G01N 2333/70589 (2013.01); G01N 2800/52 (2013.01);
Abstract

Provided are methods and compositions for isolating and detecting rare cells from a biological sample containing other types of cells, particularly including debulking that uses a microfabricated filter for filtering samples. The enriched rare cells can be used in a downstream process such as identification, characterization or growth in culture, or in other ways. Also included is a method of determining tumor aggressiveness or the number or proportion of cancer cells in the enriched sample by detecting telomerase activity, nucleic acid or expression after enrichment of rare cells. Also provided is an efficient, rapid method to specifically remove red and white blood cells from a biological sample containing at least one of the cell types, leading to enrichment of rare target cells including circulating tumor (CTC), stromal, mesenchymal, endothelial, fetal, stem, or non-hematopoietic cells et cetera from a blood sample.


Find Patent Forward Citations

Loading…